Dec 05, 2019 - Gene therapy continues to draw attention with the recent spate of deals and acquisitions. We list four stocks with promising candidates in their pipelines that make attractive acquisition targets.
Nov 22, 2019 - These dirt cheap healthcare stocks could be poised for a major upswing in 2020.
Nov 15, 2019 - Sarepta (SRPT) expands its footing in the gene therapy field and signs a deal with StrideBio to develop up to eight new treatments.
Nov 08, 2019 - Sarepta (SRPT) reports wider year-over-year loss. However, revenues increase year over year.
Nov 08, 2019 - SRPT earnings call for the period ending September 30, 2019.
Nov 08, 2019 - Sarepta Therapeutics, Inc. (NASDAQ:SRPT) Q3 2019 Earnings Conference Call November 7, 2019 16:30 ET Company Participants Ian Estepan - Senior Vice President, Chief of Staff and Corporate Affairs Dougl
Nov 07, 2019 - Sarepta Therapeutics (SRPT) delivered earnings and revenue surprises of -26.87% and 1.61%, respectively, for the quarter ended September 2019. Do the numbers hold clues to what lies ahead for the stock?
Oct 22, 2019 - Sarepta Therapeutics' (SRPT) third-quarter results are expected to reflect the impact of strong demand for Exondys 51. Regulatory update related to golodirsen is what investors are expected be focused on.
Oct 07, 2019 - Companies in the news are: COST, BP, HPQ and SRPT
Oct 04, 2019 - Sarepta Therapeutics, Inc. (NASDAQ:SRPT) Limb-Girdle Muscular Dystrophy Type 2E Functional Results Call October 4, 2019 08:00 AM ET Company Participants Ian Estepan - Senior Vice President, Chief of S